Uromodulin as a Biomarker in Lupus Nephritis
NCT07763834 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2026-08-13
Summary
Evaluation of Uromodulin as a biomarker of renal histological activity/ Chronicity indices in lupus nephritis
Conditions
- Uromodulin
- SLE
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mohsen Muhammed Hussein El Kossi · Assiut University
-
Ayat Salah Ahmed Barakat · Assiut University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-10-01
- Primary Completion
- 2029-08-02
- Completion
- 2030-03-03
More Related Trials
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Urinary G3BP as a Novel Biomarker in Lupus Nephritis
NCT06520670 ·Status: NOT_YET_RECRUITING
-
Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis
NCT03958851 ·Status: UNKNOWN
-
Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
NCT07017868 ·Status: RECRUITING
-
The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis
NCT07130448 ·Status: NOT_YET_RECRUITING
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183 ·Status: COMPLETED
-
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
NCT06610409 ·Status: NOT_YET_RECRUITING
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques
NCT03687138 ·Status: COMPLETED
-
TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis
NCT04218890 ·Status: UNKNOWN
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
NCT06063668 ·Status: NOT_YET_RECRUITING
-
Neutrophil Extracellular Traps and Lupus Nephritis
NCT07721857 ·Status: NOT_YET_RECRUITING
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
NCT06610422 ·Status: NOT_YET_RECRUITING
-
Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
NCT06796569 ·Status: RECRUITING
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Predictors of Bone Mineral Density in Lupus Nephritis Activity
NCT06837558 ·Status: NOT_YET_RECRUITING
-
Haematological Indices in Systemic Lupus Erythematosus
NCT04110184 ·Status: UNKNOWN
-
Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus
NCT05900232 ·Status: UNKNOWN ·Phase: NA
-
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
NCT06313151 ·Status: RECRUITING
-
Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE
NCT03752983 ·Status: UNKNOWN
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED